fosinopril has been researched along with benazepril in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Binder, SB | 1 |
Bicket, DP | 1 |
Pfützner, W; Przybilla, B; Ruëff, F | 1 |
Cookson, T; Gates, R; Gifford, A; Ito, M; Le, TN; Marcus, D; Nguyen, CN | 1 |
Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
Mahrouse, MA | 1 |
Abbulu, K; Bhende, SD; Varanasi, MB | 1 |
Abbenante, G; Fairlie, DP; Leung, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
5 review(s) available for fosinopril and benazepril
Article | Year |
---|---|
ACE inhibitors: review of four new agents.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Fosinopril; Heart Failure; Humans; Hypertension; Isoquinolines; Quinapril; Ramipril; Tetrahydroisoquinolines | 1993 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for fosinopril and benazepril
Article | Year |
---|---|
Three new ACE inhibitors for hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Bridged Bicyclo Compounds; Drug Interactions; Fosinopril; Heart Failure; Humans; Hypertension; Prodrugs; Proline; Ramipril | 1991 |
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines | 2004 |
Therapeutic conversion from fosinopril to benazepril at a Veterans Affairs medical center.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Fosinopril; Glomerular Filtration Rate; Hospitals, Veterans; Humans; Hypertension; Potassium; Retrospective Studies | 2006 |
Simultaneous ultraperformance liquid chromatography/tandem mass spectrometry determination of four antihypertensive drugs in human plasma using hydrophilic-lipophilic balanced reversed-phase sorbents sample preparation protocol.
Topics: Antihypertensive Agents; Benzazepines; Captopril; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Fosinopril; Humans; Hydrochlorothiazide; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Linear Models; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry | 2018 |
A sensitive and efficient LC-MS/MS method for the bioanalysis of fosinopril diacid from human plasma and its application for a bioequivalence study in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chromatography, High Pressure Liquid; Fosinopril; Humans; Male; Reference Standards; Tandem Mass Spectrometry; Therapeutic Equivalency | 2021 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |